Signal Diagnostics to pay $20.5 million over COVID uninsured-program claims

Verifying
  • Signal Diagnostics agreed to pay the United States to resolve False Claims Act allegations.
  • $20.5 million is the settlement amount for alleged Uninsured Program overpayments.
  • Signal’s audit identified claims submitted for patients with insurance, according to the allegations.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.